The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study
- 6 September 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Virchows Archiv A Pathological Anatomy and Histopathology
- Vol. 451 (5), 943-948
- https://doi.org/10.1007/s00428-007-0497-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal MetastasesJournal of Clinical Oncology, 2006
- Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver MetastasesAnnals of Surgery, 2006
- Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastasesEuropean Journal of Surgical Oncology, 2005
- Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741Annals of Oncology, 2005
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by ChemotherapyAnnals of Surgery, 2004
- Impact of steatosis on perioperative outcome following hepatic resectionJournal of Gastrointestinal Surgery, 2003
- Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III TrialJournal of Clinical Oncology, 2003
- Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis CJournal of Clinical Pathology, 2001
- Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] MetastasesAnnals of Surgical Oncology, 2001